{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 38,
  "pageCount": 53,
  "prevPage": 37,
  "nextPage": 39,
  "slideType": "appendix_disclosure",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "This is a page from a formal investigative report, likely a Congressional committee report.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/38",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-38",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Based on information and documents available to the Committee, it appears that McKinsey failed to disclose its private sector engagements that could reasonably be seen as impairing its objectivity in relation to its FDA contracts.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49d-1ec4250bfde1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.55
      },
      "kind": "paragraph",
      "text": "Based on information and documents available to the Committee, it appears that McKinsey failed to disclose its private sector engagements that could reasonably be seen as impairing its objectivity in relation to its FDA contracts, in violation of FAR Subpart 9.5 and the related disclosure requirements of several contracts.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0520ea89-2318-4f8e-9588-bf8fa24969f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.11,
        "y": 0.43
      },
      "kind": "paragraph",
      "text": "In response to a ProPublica inquiry in 2021, FDA stated that it was unable to locate any files where McKinsey disclosed its conflicts of interest to FDA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ea20f1e-5d46-405f-b8f2-d649bafa98d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.78,
        "x": 0.11,
        "y": 0.31
      },
      "kind": "paragraph",
      "text": "Despite the extensive evidence of organizational conflicts of interest at McKinsey, FDA stated in response to a request from several Senators that it was “not aware of any disclosures made by McKinsey vis-a-vis OCI [organizational conflicts of interest] in relation to” the 10 contracts that included specific language on organizational conflicts. FDA further stated that it only became aware that McKinsey had taken on opioid manufacturers as clients “in early 2021 when the information was reported in the media.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a48ba226-d8be-42eb-a1d2-e803bc264c4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.11,
        "y": 0.485
      },
      "kind": "paragraph",
      "text": "On November 5, 2021, the Committee requested that McKinsey provide “All documents disclosing or referring to a conflict of interest with FDA since 2008.” McKinsey has not produced any documents responsive to that request.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c20a0b3a-cb32-4018-a47a-cb1444248403",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.78,
        "x": 0.11,
        "y": 0.705
      },
      "kind": "source-note",
      "text": "182-185: Citations for the claims made in the text, including letters from the FDA and the Committee on Oversight and Reform.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3fb0d43-7183-486c-97e8-402e0d14e65f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.78,
        "x": 0.11,
        "y": 0.275
      },
      "kind": "title",
      "text": "3. No Evidence that McKinsey Disclosed Conflicts",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b43b3a96-4580-41c6-9bda-7e58dcba7931",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 53,
      "from": 29,
      "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 40,
      "from": 24,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "308c22ef-34f3-45b8-b50d-c273c6edeb88",
      "evidence": "The document presents the concerns of regulatory bodies through examples of McKinsey's actions and lack of disclosure.",
      "position": 1,
      "objective": "What are the concerns of regulatory bodies regarding McKinsey's conflicts of interest?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}